Lack of in vitro-in vivo correlation for a UC781-releasing vaginal ring in macaques

Drug Delivery and Translational Research
Christopher McConvilleR Karl Malcolm

Abstract

This study describes the preclinical development of a matrix-type silicone elastomer vaginal ring device designed to provide controlled release of UC781, a non-nucleoside reverse transcriptase inhibitor. Testing of both human- and macaque-sized rings in a sink condition in vitro release model demonstrated continuous UC781 release in quantities considered sufficient to maintain vaginal fluid concentrations at levels 82-860-fold higher than the in vitro IC50 (2.0 to 10.4 nM) and therefore potentially protect against mucosal transmission of HIV. The 100-mg UC781 rings were well tolerated in pig-tailed macaques, did not induce local inflammation as determined by cytokine analysis and maintained median concentrations in vaginal fluids of UC781 in the range of 0.27 to 5.18 mM during the course of the 28-day study. Analysis of residual UC781 content in rings after completion of both the in vitro release and macaque pharmacokinetic studies revealed that 57 and 5 mg of UC781 was released, respectively. The pharmacokinetic analysis of a 100-mg UC781 vaginal ring in pig-tailed macaques showed poor in vivo-in vitro correlation, attributed to the very poor solubility of UC781 in vaginal fluid and resulting in a dissolution-controlled drug r...Continue Reading

References

Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Karl MalcolmChris Andrews
Sep 13, 2005·The Journal of Antimicrobial Chemotherapy·R Karl MalcolmStephen D McCullagh
Aug 4, 2006·International Journal of Pharmaceutics·A David WoolfsonStephen D McCullagh
Mar 14, 2007·Antimicrobial Agents and Chemotherapy·D L PattonS L Hillier
Sep 21, 2007·Menopause : the Journal of the North American Menopause Society·Pratima GuptaDaniel R Mishell
May 30, 2009·Journal of Medical Primatology·Nattawan Promadej-LanierRon A Otten
Dec 9, 2010·Antiviral Research·R Karl MalcolmThomas J Smith
Mar 12, 2011·Journal of Medical Microbiology·Manjula GunawardanaMarc M Baum
Oct 7, 2011·Journal of Pharmaceutical Sciences·Meredith R ClarkPatrick F Kiser
Nov 30, 2011·Antimicrobial Agents and Chemotherapy·John A MossMarc M Baum
Dec 14, 2011·Antimicrobial Agents and Chemotherapy·Todd J JohnsonPatrick F Kiser
Feb 15, 2012·Antimicrobial Agents and Chemotherapy·R Karl MalcolmJohn P Moore
Mar 23, 2012·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Christopher Mc ConvilleR Karl Malcolm
Apr 3, 2012·Therapeutic Delivery·Lindsay M Ferguson, Lisa Cencia Rohan
Sep 12, 2012·Antimicrobial Agents and Chemotherapy·John A MossMarc M Baum
Nov 6, 2012·Expert Review of Clinical Pharmacology·Caroline purslow
Dec 4, 2012·International Journal of Women's Health·R Karl MalcolmIan Major
Sep 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·James M SmithPatrick F Kiser
Nov 1, 2013·International Journal of Women's Health·Andrea Ries ThurmanGustavo F Doncel

❮ Previous
Next ❯

Citations

Feb 2, 2016·Advanced Drug Delivery Reviews·R Karl MalcolmDiarmaid J Murphy
Sep 1, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Fatemeh Fattahi, Peter A Ward
Jul 19, 2016·Virology·Kabamba B AlexandreM Khati
Feb 2, 2021·International Journal of Pharmaceutics·Mattia TiboniLuca Casettari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

© 2021 Meta ULC. All rights reserved